Patents Assigned to Jyant Technologies, Inc.
  • Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
    Patent number: 8987210
    Abstract: This application is directed to chemokine-immunoglobulin fusion polypeptides and chemokine-polymer conjugates. The fusion polypeptides and conjugates can be used for treating chemokine receptor-mediated disorders and modulating inflammation, inflammatory cell motility, cancer cell motility, or cancer cell survival.
    Type: Grant
    Filed: August 8, 2013
    Date of Patent: March 24, 2015
    Assignee: Jyant Technologies, Inc.
    Inventor: James W. Lillard, Jr.
  • Nanoparticles for delivery of active agents
    Patent number: 8962030
    Abstract: Milled nanoparticles comprising a biologically active agent, at least one biopolymer and a coating containing at least one coating which is a polymer or ligand are produced using milling and coating techniques which have not previously been used for these applications.
    Type: Grant
    Filed: November 10, 2010
    Date of Patent: February 24, 2015
    Assignee: Jyant Technologies, Inc.
    Inventors: James W. Lillard, Rajesh Singh, Shailesh Singh